Biomedical Engineering Reference
In-Depth Information
G
OLDSMITH
P and H
ARRIS
WA (2003). The zebrafish as a tool for understanding the biology of visual
disorders. Semin Cell Dev Biol 14(1): 11-18.
H
UANG
YYandN
EUHAUSS
SC (2008). The optokinetic response in zebrafish and its applications. Front Biosci
13: 1899-1916.
H
UTCHINSON
TH, B
OGI
C, W
INTER
MJ, and O
WENS
JW (2009). Benefits of the maximum tolerated dose
(MTD) and maximum tolerated concentration (MTC) concept in aquatic toxicology. Aquat Toxicol
91(3): 197-202.
K
RAUSS
A and N
EUMEYER
C (2003). Wavelength dependence of the optomotor response in zebrafish (Danio
rerio). Vision Res 43(11): 1273-1282.
L
I
L and D
OWLING
JE (1997). A dominant form of inherited retinal degeneration caused by a non-
photoreceptor cell-specific mutation. Proc Natl Acad Sci USA 94(21): 11645-11650.
L
I
L and D
OWLING
JE (1998). Zebrafish visual sensitivity is regulated by a circadian clock. Vis Neurosci
15(5): 851-857.
L
IESCHKE
GJ and C
URRIE
PD (2007). Animal models of human disease: zebrafish swim into view. Nat Rev
Genet 8(5): 353-367.
M
AASWINKEL
H and L
I
L (2003). Spatio-temporal frequency characteristics of the optomotor response in
zebrafish. Vision Res 43(1): 21-30.
M
AKHANKOV
YV, R
INNER
O, and N
EUHAUSS
SC (2004). An inexpensive device for non-invasive electroret-
inography in small aquatic vertebrates. J Neurosci Methods 135(1-2): 205-210.
M
ATSUI
JI, E
GANA
AL, S
PONHOLTZ
TR, A
DOLPH
AR, and D
OWLING
JE (2006). Effects of ethanol on
photoreceptors and visual function in developing zebrafish. Invest Ophthalmol Vis Sci 47(10):
4589-4597.
N
EUHAUSS
SC (2003). Behavioral genetic approaches to visual system development and function in
zebrafish. J Neurobiol 54(1): 148-160.
N
EUHAUSS
SC, B
IEHLMAIER
O, S
EELIGER
MW, D
AS
T, K
OHLER
K, H
ARRIS
WA, and B
AIER
H (1999). Genetic
disorders of vision revealed by a behavioral screen of 400 essential loci in zebrafish. J Neurosci 19(19):
8603-8615.
O
RGER
MB and B
AIER
H (2005). Channeling of red and green cone inputs to the zebrafish optomotor
response. Vis Neurosci 22(3): 275-281.
O
RGER
MB, G
AHTAN
E, M
UTO
A, P
AGE
-M
C
C
AW
P, S
MEAR
MC, and B
AIER
H (2004). Behavioral screening
assays in zebrafish. Methods Cell Biol 77: 53-68.
O
RGER
MB, S
MEAR
MC, A
NSTIS
SM, and B
AIER
H (2000). Perception of Fourier and non-Fourier motion by
larval zebrafish. Nat Neurosci 3(11): 1128-1133.
R
EN
JQ and L
I
L (2004). Rod and cone signaling transmission in the retina of zebrafish: an ERG study. Int J
Neurosci 114(2): 259-270.
R
ICHARDS
FM, A
LDERTON
WK, K
IMBER
GM, L
IU
Z, S
TRANG
I, R
EDFERN
WS, V
ALENTIN
JP, W
INTER
MJ, and
H
UTCHINSON
TH (2008). Validation of the use of zebrafish larvae in visual safety assessment. J Pharmacol
Toxicol Methods 58(1): 50-58.
R
INNER
O, R
ICK
JM, and N
EUHAUSS
SC (2005). Contrast sensitivity, spatial and temporal tuning of the larval
zebrafish optokinetic response. Invest Ophthalmol Vis Sci 46(1): 137-142.
R
OESER
T and B
AIER
H (2003). Visuomotor behaviors in larval zebrafish after GFP-guided laser ablation of
the optic tectum. J Neurosci 23(9): 3726-3734.
S
ANTAELLA
RM and F
RAUNFELDER
FW (2007). Ocular adverse effects associated with systemic medications:
recognition and management. Drugs 67(1): 75-93.
S
ASZIK
S, A
LEXANDER
A, L
AWRENCE
T, andB
ILOTTA
J (2002). APBdifferentially affects the cone contributions
to the zebrafish ERG. Vis Neurosci 19(4): 521-529.
S
CHMITT
EA and D
OWLING
JE (1994). Early eye morphogenesis in the zebrafish, Brachydanio rerio. J Comp
Neurol 344(4): 532-542.
V
ALENTIN
JP and H
AMMOND
T (2008). Safety and secondary pharmacology: successes, threats, challenges
and opportunities. J Pharmacol Toxicol Methods 58(2): 77-87.
V
IHTELIC
TS, D
ORO
CJ, and H
YDE
DR (1999). Cloning and characterization of six zebrafish photoreceptor
opsin cDNAs and immunolocalization of their corresponding proteins. Vis Neurosci 16(3): 571-585.
Z
ON
LI and P
ETERSON
RT (2005). In vivo drug discovery in the zebrafish. Nat Rev Drug Discov 4(1): 35-44.
Search WWH ::
Custom Search